Search
Patexia Community

Innovation, Technology, and IP News

Medtronic Completes Acquisition of Cardiac Mapping Company Affera

Medtronic recently announced that its acquisition of Affera, Inc. has been completed. The acquisition was previously announced to be for $925 million with a...

Feed tagged as "DNA":
Anyone familiar with the fate of claims to primers used in PCR, to amplify a stretch of target DNA in order to determine whether or not a significant mutation is... Read More »
In ex parte Ho, the subject of my last post, the PTAB reversed the Examiner’s rejection of claims to a population of bone marrow cells obtained by two-stage... Read More »
On July 18th, in appeal no. 2017-007443, the PTAB reversed the Examiner’s rejection to an improved method of manipulating the huge amount of DNA sequence... Read More »
On January 25, a team at the Chinese Academy of Sciences published an online paper that will appear in Cell, 172, 1-7 (Feb. 8, 2018) reported the cloning of two... Read More »
Researchers from MIT announced last week that they have engineered tiny particles made out of RNA and DNA, utilizing a technique called “nucleic acid... Read More »
Enjoy this week’s wrap up of trending medical news!   Rats paralyzed due to spinal cord injury walking again thanks to new therapy Rats that... Read More »
Here's your weekly wrap up of the top medical news! Baby kept alive with world’s smallest artificial heart Italian doctors are reporting that... Read More »
Comments
Aurora SterlingThe connections between industry and research are always interesting
Jul 5, 2012
Exercise alters your DNA  ... well, sort of. Your DNA is not really altered. Exercise cannot rewrite your genetic code. I’m sorry, but exercising will not... Read More »
Here’s your weekly collection of medical news making waves this week. Robotic surgery: Improving patient outcomes and opening the door for telesurgery... Read More »
  The US Court of Appeals has ruled that isolated genes from human DNA structures are patentable in the case of The Association for Molecular Pathology... Read More »
Comments
Gena PatentAlthough a bit of trepidation is likely in order (no matter on what end of the spectrum you tend to fall), I look forward to reading what the SCOTUS has to say when the esteemed Justices opine on gene patents. Particularly since Myriad presents a bit of a chicken-and-egg question -- that is thus perhaps not scientifically, definitively solvable -- policy considerations will probably weigh heavily in their ultimate determination. Which also makes one wonder to what extent the Court's new political makeup will affect the case's outcome.http://www.GeneralPatent.com/blog/
Aug 9, 2011
Menu